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Abstract
Background: Increased co-morbidities and physiological changes mean older patients may be at higher risk of
adverse outcomes from certain imported illnesses. One of the most commonly diagnosed imported infections in
returning travelers is malaria. Increasing age is strongly and independently associated with increasing morbidity and
mortality from malaria. Delayed diagnosis leads to higher risks of poor clinical outcomes in older patients presenting
with malaria. The objective of this study was to quantify malaria presentations in older patients as a percentage of total
malaria presentations, compare length of hospital stay (LOS) between the older and younger cohort, and to describe
medical co-morbidities, length of time to diagnosis and factors contributing to delayed diagnosis and increased LOS in
the older cohort.
Methods: A retrospective cohort study was undertaken in two university hospitals of all patients aged 65 years or
older presenting with malaria from 2002–2012. A national hospital inpatient database was used to identify patients of
all ages with a discharge diagnosis of malaria over this ten year period, and quantify LOS in those aged <65 and those
aged 65 years or older. The case-notes for all of the older cohort were reviewed.
Results: There were a total of 203 cases, 12 of whom were aged ≥65 years (5.9 %- total). Median time to diagnosis in
this older group was two days (range 0–35), median LOS was eight days (range 1–77), compared to a median LOS of
three days in those aged <65 years. All patients aged ≥65 years presented with fever. Travel history was documented
in only 6/12 charts, and 11/12 had two or more co-morbid illnesses. Six of the 12 patients were not diagnosed or
treated within 48 h of presentation.
Conclusions: This case series highlights the need for appropriate history-taking and timely diagnosis of the older traveler
returning with fever, as delayed diagnosis and treatment can contribute to prolonged hospital stay and increased
morbidity. With increasing numbers of older travelers, physicians must remain vigilant to the presence of imported
illnesses, particularly malaria, in older patients with unexplained fever.
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Background
Older individuals account for a significant proportion of
travelers [1–3] and the number of older people traveling
is increasing, in keeping with increasing numbers of
travelers of all age [4]. There is greater access to global
malaria-endemic areas, and increased bi-directional mi-
gration between regions. Due to increased number of
co-morbidities and physiological changes, these older
patients are at higher risk of adverse outcomes from cer-
tain imported illnesses, particularly malaria [3], therefore
it is of paramount importance to diagnose these
infections as quickly as possible. One of the most
commonly diagnosed imported infections in febrile
travellers returning to Europe is malaria [4–7].
Malaria, in particular malaria due to Plasmodium fal-
ciparum, is associated with a high rate of morbidity
and mortality. Increasing age is strongly and inde-
pendently associated with increasing risk of death
from malaria [8–11]. Prior studies have reported
higher risks for severe malaria and adverse outcomes
in older patients presenting with malaria [12–17], par-
ticularly in the setting of delayed diagnosis [9] and
therefore any delay to diagnosis can be critical.
Appropriate targeted history taking in any patient
returning from abroad, and most importantly those
presenting with fever, can lead to early diagnosis of
imported illnesses, and thereby improve clinical outcomes,
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decrease length of hospital stay, and decrease overall mor-
bidity and mortality.
The objective of this study was to quantify malaria
presentations in older patients as a percentage of total
malaria presentations, and to describe medical co-
morbidities, length of time to diagnosis and length of
hospital stay in the older cohort. Each case of malaria in
an older patient was reviewed in detail to assess whether
travel history was being considered in older patients, to
quantify delays to diagnosis and treatment, and to assess
the impact of patient demographic factors and medical
co-morbidities, in order to identify reasons for poorer
clinical outcomes.
Methods
First, a Hospital In-patient Enquiry (HIPE) was used to
identify all patients with a discharge diagnosis of malaria
from 2002–2012 in two university hospitals in the
Republic of Ireland. HIPE is a national database designed
to collect demographic, clinical and administrative data
on discharges from acute public-sector hospitals nation-
ally in the Republic of Ireland [18]. Secondly, the case-
notes of those aged ≥65 years who were initially identi-
fied by HIPE were reviewed. A case report form was
designed to collect information about patient demo-
graphics and co-morbidities, presenting features, time to
diagnosis, potential factors contributing to delayed diag-
nosis, and length of hospital stay (LOS) in the older
population. The cases of malaria in patients aged <65
were quantified from the HIPE data for comparison with
respect to length of stay.
The extraction of information from the case-notes was
done by the main researcher, who was a medical doctor
working in the two hospitals. The case report forms did
not contain any personal identifying information, and
therefore all datasets generated were anonymous.
Statistical analysis was performed using IBM SPSS
statistics version 20®.
The study was in accordance with the ethical standards
of the institutions and was deemed exempt from the need
for further approval from the ethics review board.
Results
There were a total of 203 cases of malaria over the
examined ten year period, 12 of whom were aged
65 years or older (5.9 %).
Patient characteristics in older cohort
Ten patients (83.3 %) were Caucasian, two (16.6 %) were
Black; seven (58.3 %) were male. The median age was
67.5 (range 65–80). Twenty-five percent (3/12) were
returning missionaries. All patients presented with a his-
tory of fever, and 10/12 patients had a documented fever
on presentation. (Median temperature at presentation
38.4 degrees Celsius). Other common presenting
features were malaise (10/12), headache (9/12), gastro-
intestinal symptoms (8/12), and less commonly arthral-
gia (2/12) and jaundice (2/12). The patients had a me-
dian of 2.5 days of symptoms prior to presentation
(range 1–7). Ninety-two percent (11/12) of the patients
had two or more significant co-morbid illnesses, includ-
ing hypertension (n = 5), respiratory disease (n = 4),
ischaemic heart disease (n = 4), lipid disorders (n = 3),
lymphoma (n = 1), haematological disorders (n = 2) and
hepatitis C virus infection (n = 1).
Time to diagnosis and clinical course in older cohort
Median time from presentation to diagnosis was two
days (range 0–35) in the older cohort. Only 50 % (6/12)
of patients were diagnosed on admission. Of those who
were not diagnosed on admission, the median time to
diagnosis was five days (range 2–35). Factors contribut-
ing to delayed diagnosis included coexistent confound-
ing illness and lack of awareness of travel history. In half
of the cases (6/12) a travel history was not documented.
As above, almost all patients (92 %) had co-morbidities,
and of the six who were not diagnosed on admission,
five of these were commenced on treatment for alterna-
tive diagnoses, and one was admitted for further investi-
gation. None of the patients who had a delay to
diagnosis were commenced on empiric treatment for
malaria, nor was malaria documented in the differential
diagnosis. Two cases were later incidentally diagnosed
when the laboratory noticed trophozoites of Plasmodium
falciparum on full blood count. One of these was a com-
plicated case of Hepatitis C seroconversion who pre-
sented with jaundice. Hepatitis C was diagnosed prior
to, and may have delayed, the subsequent diagnosis of
malaria. The patient had a prolonged stay with coagula-
tion defects and severe hospital-acquired pneumonia,
and an eventual finding of plasmodium falciparum tro-
phozoites on blood film on day 35 of admission. The pa-
tient was finally discharged home well after a 77-day
hospital admission. One patient who presented with a
history of fever but otherwise quite well was initially sent
home, and was only diagnosed on re-presentation with
worsening symptoms.
With regards to the type of malaria, all patients had
Plasmodium falciparum trophozoites on blood film, and
one patient was co-infected with Plasmodium vivax.
This patient had a previous history of Plasmodium vivax
infection, which had been treated abroad four years earl-
ier. It is unclear whether this presentation was relapse or
re-infection. In the six cases where travel history was
documented, two had documented use of anti-malarial
prophylaxis, two had not used prophylaxis, and for the
final two there was no documentation about use of
prophylaxis.
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Length of stay and factors contributing to prolonged
hospital stay
Median length of hospital stay in the ≥65 s was eight days
(range 1–77), compared to a median LOS of three days
(range 1–11) in the <65 yr cohort . Reasons for the pro-
longed stay included the development of associated infec-
tions (3/12 patients), delays in identifying the cause of
fever and therefore delays to initiation of treatment (as
above). Added to this was a slow recovery phase once
malaria treatment was instituted, possibly due to de-
creased resilience and increased medical co-morbidities.
Despite varying clinical courses and complications, all 12
patients were eventually discharged home well.
Discussion
Our retrospective case review identified a small but
significant proportion of cases of imported malaria
occurring in patients aged ≥65 years, as have other
studies [3, 4, 8–10, 13–16]. It is well-established that
older patients have worse clinical outcomes when pre-
senting with imported malaria. Checkley et al. looked
at over 25,000 patients with Plasmodium falciparum
malaria presenting in the United Kingdom (UK) be-
tween 1987 and 2006, and case fatality rate was
shown to be 4.6 % in those aged >65 years [8]. Ac-
cording to the European Network on Imported Dis-
ease Surveillance Data, the risk in elderly patients is
almost six times higher in the >60 age group [13].
Similarly Saliba et al. showed that age >40 years was
independently predictive of severe malaria [17]. While
none of our small cohort died, their collective LOS
and complicated clinical courses support the existing
data on worse morbidity in the older age group.
We found a high LOS in the patients aged ≥65 years,
and significant delays in time from presentation to diag-
nosis. A literature review by Luthi et al. showed that age,
delay in seeking care, delayed diagnosis, and delayed ad-
ministration of the correct treatment are some of the
main risk factors for fatal malaria in travellers [10].
Other studies looking at delays to diagnosis have mainly
commented on delay between onset of symptoms and
patient seeking care [9, 15]. A US study by Newman
et al. showed a median of 4.5 days from symptom onset
to presentation, which is higher than our median of
2.5 days [19]. A cohort study in France conducted be-
tween 1996 and 2003, which included more than 20,000
patients, found that the median time from onset of
symptoms to diagnosis was three days, but this was not
broken down into time to presentation and time from
presentation to diagnosis [9]. The indicator that we are
presenting (delay from presentation to diagnosis) could
be considered a useful one in evaluating the perform-
ance of the secondary/tertiary health care system.
A small number of other studies have looked at delays
to diagnosis and/or treatment after presentation to a
health care facility. In a US study of malaria-related
deaths among travelers from 1963–2001, a remarkable
67.8 % of persons who died did not obtain a correct
diagnosis on the day of presentation (range 1–17 days to
achieve the correct diagnosis) [19]. In a paper by Santos
et al. the mean time between arrival and diagnosis was
eight days in patients who survived, and 16 days in pa-
tients who had a fatal outcome ie) delayed diagnosis was
associated with a fatal outcome [20]. With regard to rea-
sons for this delay, in our study the main contributing
factors were co-morbidities and confounding illness (11/12
patients had two or more co-morbidities, and five patients
were initially diagnosed with pathologies other than mal-
aria), and the lack of awareness of travel history (we could
not establish for how many patients travel history was not
collected as the absence of travel history in the chart could
mean either no travel history or that the patient was not
asked). In a Swiss study, 2/11 cases of malaria that had un-
usual transmission were fatal, and this high case fatality rate
was thought to be related to a late diagnosis due to missing
history or a history that did not point towards malaria as a
possibly diagnosis [21]. The coexistence of a confounding
illness is a challenge that clinicians face daily, not only in
these specific presentations. Detailed history taking is vital
for rapid diagnosis of any presenting illness, and, clearly,
omitting a travel history means that vital diagnostic infor-
mation is missing.
As expected, we found longer lengths of stay in this
older population (median eight days versus median three
days in the under 65 year age group). The median stay
of three days in the younger cohort is in keeping with
median LOS found in other studies, such as a French
cohort study where the median length of stay across all
age groups was three days [9]. To our knowledge no
other studies have commented on LOS with specific ref-
erence to or comparison with older individuals. The
aforementioned co-morbidities also very likely contributed
to the longer LOS in the older cohort, along with host-
specific factors in older patients leading to different im-
munological responses and levels of parasitaemia [22, 23].
In our study, the delay from first presentation to diag-
nosis correlated with a delay in treatment initiation,
which also had an impact on the longer LOS in this
group. A large UK-based observational study showed
that for the most part, prompt treatment followed a
diagnosis of severe malaria in a specialist centre (median
diagnosis-to-treatment time was 1 h (range 0.5-5) for pa-
tients receiving artesunate in the specialist centre). Sig-
nificant delays from diagnosis to treatment were only
seen in regional centers who did not have artesunate on
site. The fact that treatment promptly followed diagnosis
in specialist centers is generalisable to our study, which
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was performed in two tertiary referral centers, and
therefore we can assume that our delays in treatment
were due to delay in diagnosis [24].
Our study did not calculate the median delay to diag-
nosis in the younger age-group, which did not allow for
direct comparison. However, we do know that the me-
dian delay from presentation to diagnosis was two days
in the older group, and the median LOS in the younger
group was three days. Therefore if the patients with mal-
aria from the younger cohort were discharged on day
three (median) after presentation we can assume that
their correct diagnosis must have been secured for the
most part on day one.
This study has other limitations, not least of which are
its small numbers. This, and the fact that the study was
conducted in only two centers, means that caution must
be taken with generalizing results. However, even in set-
tings that would expect to see even fewer presentations
of imported infection, it is important for physicians to
remain alert to the possibility; a large study in the UK
showed that while most UK cases are seen in hospitals
which see a lot of malaria cases, 25 % of falciparum mal-
aria is seen in centers which see less than one malaria
patient a month, and 6 % in hospitals that see fewer than
two cases per year [24]. Furthermore case-notes reviews
have their limitation; the non-documentation of ques-
tions relating to travel history and use of malaria
prophylaxis were taken to mean that these questions
were not asked, which may not be the case. Finally the
HIPE system also has limitations – use of this system
only captures data pertaining to patients on whom a dis-
charge summary was completed by medical staff.
Conclusion
Older individuals represent a small but substantial pro-
portion of travelers, and subsequently of patients pre-
senting with imported infections such as malaria. As
worldwide travel becomes more accessible older individ-
uals are likely to represent an increasing proportion of
patients returning with imported illness. As in any case,
early diagnosis is essential, and is largely dependent on
detailed accurate travel history retrieval. This case series
reiterates the importance of early consideration of the
possibility of malaria in at-risk patients as a delay to
diagnosis can result in prolonged hospital stay and in-
creased morbidity.
This case series also highlights certain challenges to
the identification of imported infection in older patients,
such as the varied presenting features, especially in
patients with other co-morbid illnesses, as well as the
possible omission of a quick but vital travel history.
While this study suggests that older patients still only
account for a small proportion of patients diagnosed
with malaria in these centers, with increasing numbers
of older travelers this proportion may increase in line
with the general ageing population over the coming
years. Physicians must remain vigilant to the potential
presence of imported infections, especially malaria, in
both younger and older patients with unexplained fever
and a history of travel.
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